TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 7.83
(-13.29%)
TWD 7.83
(-13.29%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 29.35 Million TWD | 14.1% |
| 2022 | 25.72 Million TWD | -19.06% |
| 2021 | 31.78 Million TWD | -21.29% |
| 2020 | 40.37 Million TWD | -1.54% |
| 2019 | 41.01 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 6.74 Million TWD | 23.48% |
| 2024 Q1 | 5.46 Million TWD | -44.18% |
| 2023 Q1 | 4.71 Million TWD | -59.77% |
| 2023 Q3 | 9.78 Million TWD | 107.41% |
| 2023 Q4 | 9.78 Million TWD | 0.0% |
| 2023 FY | 29.35 Million TWD | 14.1% |
| 2023 Q2 | 4.71 Million TWD | 0.0% |
| 2022 Q3 | 11.72 Million TWD | 0.0% |
| 2022 FY | 25.72 Million TWD | -19.06% |
| 2022 Q4 | 11.72 Million TWD | 0.0% |
| 2021 FY | 31.78 Million TWD | -21.29% |
| 2020 FY | 40.37 Million TWD | -1.54% |
| 2019 FY | 41.01 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -8821.581% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 77.009% |
| Level Biotechnology Inc. | 151.99 Million TWD | 80.689% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 78.394% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 61.307% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 86.968% |
| GlycoNex Incorporation | 995 Thousand TWD | -2849.95% |
| VBI | 32.55 Million TWD | 9.839% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 88.573% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 84.885% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 36.223% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 75.522% |
| Visgeneer Inc. | 67.48 Million TWD | 56.504% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 107.823% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 94.246% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 54.068% |
| Neith Corporation | 66.87 Million TWD | 56.108% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 97.967% |
| Enimmune corporation | 220.1 Million TWD | 86.664% |
| TaiRx, Inc. | 217.13 Million TWD | 86.482% |
| CHO Pharma, Inc. | 268.99 Million TWD | 89.088% |
| EirGenix Inc. | 236.74 Million TWD | 87.602% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 71.872% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 91.792% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 97.324% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 88.972% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 40.668% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -2610.249% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 83.459% |
| RBC Bioscience Corporation | 58.35 Million TWD | 49.702% |
| BiOptic Inc. | 108.69 Million TWD | 72.995% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -32513.333% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 57.676% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1022.447% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 95.442% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 68.552% |
| NaviFUS Corp. | 11.82 Million TWD | -148.178% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 84.611% |
| Sinew Pharma Inc. | 186.25 Million TWD | 84.241% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 60.347% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 86.682% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 29.24% |
| AP Biosciences Inc | 32.25 Million TWD | 8.995% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 98.414% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -456.542% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 90.75% |
| Intech Biopharm Corporation | -163.99 Million TWD | 117.898% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 97.401% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 29.242% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 82.689% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 80.036% |
| TCI GENE Inc. | 174.61 Million TWD | 83.191% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -162966.667% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 90.246% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 89.912% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 65.034% |
| PharmaEngine, Inc. | 441.78 Million TWD | 93.356% |
| Savior Lifetec Corporation | 223.36 Million TWD | 86.859% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 88.658% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 98.544% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 78.864% |
| Acepodia, Inc. | 452.56 Million TWD | 93.514% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 94.574% |